Skip to Content
You are currently on the new version of our website. Access the old version .

3 Results Found

  • Article
  • Open Access
14 Citations
6,586 Views
14 Pages

A Pharmacokinetic Study Comparing the Clearance of Vancomycin during Haemodialysis Using Medium Cut-Off Membrane (Theranova) and High-Flux Membranes (Revaclear)

  • Hussain Allawati,
  • Linda Dallas,
  • Sreejith Nair,
  • Janine Palmer and ,
  • Shaiju Thaikandy and
  • Colin Hutchison
  • + 1 author+ 0 author

12 May 2020

Medium cut-off membrane (MCO) dialysers have been shown to remove a range of middle molecules, which are associated with adverse outcomes in haemodialysis (HD) patients, more effectively than high-flux HD. Vancomycin is widely used in HD patients for...

(This article belongs to the Special Issue Immune Dysfunction in Uremia)
  • Article
  • Open Access
1,503 Views
14 Pages

14 December 2025

Background/Objectives: Uremic middle molecules contribute to chronic inflammation and symptom burden in hemodialysis patients. The Theranova 500 medium-cutoff (MCO) dialyzer enhances clearance of larger uremic toxins and may offer clinical advantages...

(This article belongs to the Special Issue Peritoneal Dialysis and Hemodialysis: Early and Late Outcomes)
  • Article
  • Open Access
3 Citations
899 Views
21 Pages

In Vitro Thrombogenicity Evaluation of Hemodialyzers

  • Adam M. Zawada,
  • Robert Nitschel,
  • Craig Kamerath,
  • Nathan Crook and ,
  • Skyler Boyington and
  • Ansgar Erlenkoetter
  • + 1 author+ 0 author

25 February 2026

Investigation of dialyzer thrombogenicity is a critical step during the development of a new dialyzer. Novel dialyzer membranes aim to reduce the inherent thrombogenic potential of artificial surfaces by, e.g., increasing membrane hydrophilicity. Rel...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)